NICE expands draft recommendation for Lokelma
The news comes shortly after AZ announced positive results from a late-stage trial of the drug.
Read More
Tag: Final Appraisal Document
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
